[A new basic agent, prospidin, in the therapy of rheumatoid arthritis. Research on its clinical effectiveness in a controlled and double-blind trial].
D000328:Adult; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D010919:Placebos; D011447:Prospidium / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D010879:Piperazines; D010919:Placebos; D011447:Prospidium
Novoe bazisnoe sredstvo prospidin v terapii revmatoidnogo artrita. Issledovanie klinicheskoĭ éffektivnosti v kontroliruemom i dvoĭnom slepom opyte.